ArticleScientific reports2025
Controlled delivery of PRP from decellularized extracellular matrix enhances skeletal muscle regeneration.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Exploration of the Therapeutic Protocols and Underlying Molecular Mechanisms of Autologous Platelet-Rich Plasma in the Treatment of Deep Second-Degree Burns.Journal of cosmetic dermatology · 2026Trial
- Sandwiching Muscle Acellular Reconstruction Technique: An Early Feasibility Technique for Acute Skeletal Muscle Transection Stabilization.Plastic and reconstructive surgery. Global open · 2026Article
- Heparin-Modified Aligned Collagen Scaffolds Enhance In Vitro Myogenesis.Journal of biomedical materials research. Part A · 2026Article
- Mouse Models of Muscle Fibrosis: Mechanisms, Methods, and Applications.Biomedicines · 2026Review
- Heparin-modified aligned collagen scaffolds enhancebioRxiv : the preprint server for biology · 2025Article
- Heparin-Based Growth Factor Delivery Platforms: A Review.Pharmaceutics · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The efficacy of platelet-rich plasma (PRP) in enhancing muscle regeneration was limited due to uncontrolled delivery. This study focuses on modification of decellularized scaffolds derived from skeletal muscle extracellular matrix (ECM) by heparin, loading with PRP, to enhance endogenous cell recruitment in muscle regeneration. Here, we showed an optimal decellularization procedure that effectively removed cells while preserving the ECM components in skeletal muscle tissue and the macroporous scaffolds showed suitable physical and mechanical properties for muscle tissue engineering. Heparinized scaffold released platelet-derived growth factor (PDGF), fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) in a sustained manner. Moreover, the scaffold increased the metabolic activity and myogenic differentiation of C2C12 cells. In addition, histological analysis revealed higher angiogenesis and more extensive migration of the host muscle cells in the volumetric muscle loss (VML) model. The heparinized scaffold facilitated the attraction and sustained release of growth factors from PRP, which in turn promoted the recruitment of the endothelial and muscle cells in the injured tissue that may have the potential to enhance the accessibility of decellularized scaffolds for off-the-shelf use and to treat muscle defects in clinical practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.